Antibodies specifically directed to a soluble form of CTLA-4

Frank James Ward (Inventor), Robert Norman Barker (Inventor), Lekh Nath Dahal (Inventor)

Research output: Patent

27 Downloads (Pure)

Abstract

The invention provides materials and methods relating to antibodies specific for a soluble form of CTLA-4 (sCLTA-4). Such antibodies have been shown to have a strong boosting effect on antigen-specific human immune responses.
Original languageEnglish
Patent numberUS8697845 B2
Priority date15/04/14
Publication statusPublished - 2 Sep 2010

Fingerprint

HLA-D Antigens
Antibodies

Cite this

Ward, F. J., Barker, R. N., & Dahal, L. N. (2010). Antibodies specifically directed to a soluble form of CTLA-4. (Patent No. US8697845 B2).

Antibodies specifically directed to a soluble form of CTLA-4. / Ward, Frank James (Inventor); Barker, Robert Norman (Inventor); Dahal, Lekh Nath (Inventor).

Patent No.: US8697845 B2.

Research output: Patent

Ward, FJ, Barker, RN & Dahal, LN 2010, Antibodies specifically directed to a soluble form of CTLA-4, Patent No. US8697845 B2.
Ward FJ, Barker RN, Dahal LN, inventors. Antibodies specifically directed to a soluble form of CTLA-4. US8697845 B2. 2010 Sep 2.
Ward, Frank James (Inventor) ; Barker, Robert Norman (Inventor) ; Dahal, Lekh Nath (Inventor). / Antibodies specifically directed to a soluble form of CTLA-4. Patent No.: US8697845 B2.
@misc{2517a5b375cc4fb4845b576ae597911b,
title = "Antibodies specifically directed to a soluble form of CTLA-4",
abstract = "The invention provides materials and methods relating to antibodies specific for a soluble form of CTLA-4 (sCLTA-4). Such antibodies have been shown to have a strong boosting effect on antigen-specific human immune responses.",
author = "Ward, {Frank James} and Barker, {Robert Norman} and Dahal, {Lekh Nath}",
year = "2010",
month = "9",
day = "2",
language = "English",
type = "Patent",
note = "US8697845 B2",

}

TY - PAT

T1 - Antibodies specifically directed to a soluble form of CTLA-4

AU - Ward, Frank James

AU - Barker, Robert Norman

AU - Dahal, Lekh Nath

PY - 2010/9/2

Y1 - 2010/9/2

N2 - The invention provides materials and methods relating to antibodies specific for a soluble form of CTLA-4 (sCLTA-4). Such antibodies have been shown to have a strong boosting effect on antigen-specific human immune responses.

AB - The invention provides materials and methods relating to antibodies specific for a soluble form of CTLA-4 (sCLTA-4). Such antibodies have been shown to have a strong boosting effect on antigen-specific human immune responses.

UR - https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140415&DB=EPODOC&locale=en_EP&CC=US&NR=8697845B2&KC=B2&ND=5

M3 - Patent

M1 - US8697845 B2

ER -